Answers are grounded in this paper and cite their sources.
This paper offers an overview of how end-of-life care is currently financed in the USA. It discusses the limitations of the current system, as well as certain population and disease trends that lead us to recommend how financing should be restructured so that optimal end-of-life care is available for the entire population.
No takes yet. Share an insight, caveat, or question.
Raphael et al. (2001) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: